Pradžia › Plaučių vėžys › Masčusetsas › Worcester
Plaučių vėžys klinikiniai tyrimai Worcester, MA
11 tyrimai dėl Plaučių vėžys ieško dalyvių vietose Worcester ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Renkami dalyviai3 fazė
- UMass Memorial Medical Center - University Campus, Worcester
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Renkami dalyviai3 fazė
- Dana-Farber/Brigham and Women's Cancer Center at Milford Regional, Milford · už 17 mylių
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Renkami dalyviai3 fazė
- UMass Memorial Medical Center - University Campus, Worcester
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Renkami dalyviai3 fazė
- UMass Memorial Medical Center - University Campus, Worcester
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Renkami dalyviai3 fazė
- Reliant Medical Group Inc, Worcester
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Renkami dalyviai3 fazė
- University of Massachusetts Memorial Medical Center, Worcester
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Renkami dalyviai3 fazė
- UMass Memorial Medical Center - University Campus, Worcester
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Renkami dalyviai2 fazė
- UMass Memorial Medical Center - University Campus, Worcester
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Renkami dalyviai2 fazė
- UMass Memorial Medical Center - University Campus, Worcester
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Renkami dalyviai2/3 fazė
- UMass Memorial Medical Center - University Campus, Worcester
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Renkami dalyviaiStebimasis tyrimas
- Massive Bio SYNERGY-AI site, Worcester
Plaučių vėžys tyrimai kituose miestuose
- Houston, TX78 tyrimai
- Boston, MA62 tyrimai
- New York City, NY60 tyrimai
- Los Angeles, CA45 tyrimai
- Washington, DC41 tyrimas
- Arlington, VA41 tyrimas
- Chicago, IL41 tyrimas
- Nashville, TN40 tyrimai
- Baltimore, MD40 tyrimai
- St. Louis, MO39 tyrimai
- Columbus, OH37 tyrimai
- Philadelphia, PA36 tyrimai
Kiti tyrimai Worcester
- Nedidelinių ląstelių plaučių vėžys14 tyrimai
- Vėžys (visų tipų)7 tyrimai
- Krūties vėžys6 tyrimai
- Šizofrenija5 tyrimai
- Metastatinis vėžys5 tyrimai
- Prostatos vėžys5 tyrimai
- Kiaušidžių vėžys5 tyrimai
- Didelis depresinis sutrikimas5 tyrimai
- Depresija5 tyrimai
- Ūmi mieloidinė leukemija5 tyrimai
- Urotelinis (pereinamųjų ląstelių) karcinoma4 tyrimai
- Šlapimo pūslės vėžys4 tyrimai
Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.